Is 89bio, Inc. technically bullish or bearish?
2025-10-14 11:37:41As of 10 October 2025, the technical trend for 89bio, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the moving averages on a daily basis also indicate bullishness. However, the weekly and monthly RSI readings are bearish, suggesting some weakness. The Bollinger Bands show a mildly bullish stance on the weekly and bullish on the monthly. The OBV is mildly bearish on the weekly timeframe. In terms of returns, the stock has significantly outperformed the S&P 500 over the past month (83.4% vs. 0.31%) and year-to-date (89.26% vs. 11.41%), but has underperformed over the longer three-year and five-year periods. Overall, the current stance is mildly bullish, with mixed signals from various indicators....
Read MoreIs 89bio, Inc. technically bullish or bearish?
2025-10-13 11:39:15As of 10 October 2025, the technical trend for 89bio, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the weekly and monthly RSI readings are bearish, and the OBV is mildly bearish on a weekly basis. The Bollinger Bands show a mildly bullish trend weekly and bullish monthly. Overall, the mixed indicators suggest a mildly bullish stance with some caution due to bearish RSI readings. In terms of performance, 89bio has significantly outperformed the S&P 500 over the past month (73.71% vs. 0.31%) and year (98.92% vs. 13.36%), but it has underperformed over the 5-year and 10-year periods....
Read MoreIs 89bio, Inc. technically bullish or bearish?
2025-10-12 11:27:17As of 10 October 2025, the technical trend for 89bio, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the weekly and monthly RSI readings are bearish, and the OBV is mildly bearish on a weekly basis. The Bollinger Bands show a mildly bullish trend weekly and bullish monthly. Overall, the technical stance is mildly bullish, with mixed signals from the indicators. In terms of performance, 89bio has significantly outperformed the S&P 500 over the past month (73.71% vs. 0.31%) and year (98.92% vs. 13.36%), but has underperformed over the 5-year and 10-year periods....
Read MoreIs 89bio, Inc. technically bullish or bearish?
2025-10-07 12:20:59As of 3 October 2025, the technical trend for 89bio, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by weekly and monthly MACD readings, which are both bullish, as well as bullish signals from Bollinger Bands and KST. Daily moving averages also indicate a bullish trend. However, the RSI readings are bearish on both weekly and monthly time frames, suggesting some weakness in momentum. In terms of performance, the stock has significantly outperformed the S&P 500 over multiple periods, with a 1-month return of 67.64% compared to the S&P 500's 4.15%, and a 1-year return of 106.82% versus 17.82%. Overall, while the technical indicators are predominantly bullish, the bearish RSI may indicate caution in the short term....
Read MoreIs 89bio, Inc. technically bullish or bearish?
2025-10-06 12:10:50As of 3 October 2025, the technical trend for 89bio, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by weekly and monthly bullish signals in MACD, Bollinger Bands, and daily moving averages. However, the weekly and monthly RSI readings are bearish, indicating some weakness. The KST shows a mildly bearish trend on the weekly but bullish on the monthly, while the OBV is bullish on the weekly. In terms of performance, the stock has significantly outperformed the S&P 500 over the past month (60.71% vs. 4.15%) and year-to-date (89.90% vs. 14.18%), but it has underperformed over the 5-year and 10-year periods. Overall, the bullish indicators suggest a positive outlook despite some mixed signals in the shorter-term metrics....
Read MoreIs 89bio, Inc. technically bullish or bearish?
2025-10-05 11:55:54As of 3 October 2025, the technical trend for 89bio, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals from the weekly and monthly MACD, Bollinger Bands, and daily moving averages. However, the weekly and monthly RSI readings are bearish, indicating some weakness in momentum. The KST shows a mildly bearish trend on the weekly but bullish on the monthly, while the OBV is bullish on the weekly. In terms of performance, 89bio has significantly outperformed the S&P 500 over the past month (60.71% vs. 4.15%) and year (107.40% vs. 17.82%), but it has underperformed over the 5-year and 10-year periods. Overall, while the bullish indicators suggest a positive outlook, the bearish RSI readings indicate caution....
Read MoreIs 89bio, Inc. technically bullish or bearish?
2025-09-20 20:08:23As of 11 September 2025, the technical trend for 89bio, Inc. has changed from sideways to mildly bullish. The current stance is mildly bullish, supported by a bullish MACD on the weekly and a mildly bullish MACD on the monthly. Bollinger Bands are bullish on both weekly and monthly time frames, while daily moving averages are also bullish. However, the RSI indicates bearish momentum on both weekly and monthly charts, and the KST shows a mildly bearish signal on the weekly. Dow Theory indicates no trend on both weekly and monthly time frames, and the OBV is mildly bearish on the weekly. In terms of performance, the stock has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 91.30% compared to the S&P 500's 12.22%, and a one-year return of 80.02% versus 17.14%....
Read More
89bio, Inc. Hits New 52-Week High of $15.06, Up 76.62%
2025-09-19 13:13:2789bio, Inc. has achieved a new 52-week high of USD 15.06, reflecting a significant increase in its stock performance over the past year. With a market capitalization of USD 1,271 million, the company has shown a strong upward trend, despite being a loss-making entity.
Read More





